| Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis B Kovic, X Jin, SA Kennedy, M Hylands, M Pędziwiatr, A Kuriyama, ... JAMA Internal Medicine, 2018 | 125 | 2018 |
| Google Search as an Additional Source in Systematic Reviews J Piasecki, M Waligora, V Dranseika Science and Engineering Ethics, 2017 | 104 | 2017 |
| Research in disaster settings: a systematic qualitative review of ethical guidelines S Mezinska, P Kakuk, G Mijaljica, M Waligóra, D O'Mathúna BMC Medical Ethics 17 (62), 1-11, 2016 | 87 | 2016 |
| A systematic review on how patients value chronic obstructive pulmonary disease outcomes Y Zhang, RL Morgan, P Alonso-Coello, W Wiercioch, MM Bała, ... European Respiratory Journal, 2018 | 79* | 2018 |
| Child’s assent in research: Age threshold or personalisation? M Waligora, V Dranseika, J Piasecki BMC medical ethics 15, 1-7, 2014 | 69 | 2014 |
| Umbrella and basket trials in oncology: ethical challenges K Strzebonska, M Waligora BMC Medical Ethics 20, 2019 | 48 | 2019 |
| Relevant Information and Informed Consent in Research: In Defense of the Subjective Standard of Disclosure V Dranseika, J Piasecki, M Waligora Science and Engineering Ethics, 1-11, 2016 | 46 | 2016 |
| Risk and surrogate benefit for pediatric phase I trials in oncology: a systematic review with meta-analysis M Waligora, MM Bala, M Koperny, MT Wasylewski, K Strzebonska, ... PLoS medicine 15 (2), e1002505, 2018 | 45 | 2018 |
| Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe M Broga, G Mijaljica, M Waligora, A Keis, A Marusic Science and Engineering Ethics, Springer, 2013 | 29 | 2013 |
| What Do Ethical Guidelines for Epidemiology Say About an Ethics Review? A Qualitative Systematic Review J Piasecki, M Waligora, D Vilius Science and Engineering Ethics 23 (3), 743–768, 2017 | 23 | 2017 |
| Wstęp do fenomenologii M Waligóra Towarzystwo Autorów i Wydawców Prac Naukowych UNIVERSITAS, 2013 | 23 | 2013 |
| Forensic uses of research biobanks: should donors be informed? V Dranseika, J Piasecki, M Waligora Medicine, Health Care and Philosophy, 1-6, 2015 | 19 | 2015 |
| Non-beneficial pediatric research: individual and social interests J Piasecki, M Waligora, V Dranseika Medicine, Health Care and Philosophy 18, 103-112, 2015 | 18 | 2015 |
| Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis K Strzebonska, MT Wasylewski, L Zaborowska, N Riedel, S Wieschowski, ... BMJ Open, 2020 | 15 | 2020 |
| Failures in clinical trials in the European Union: Lessons from the Polish experience M Waligora Science and engineering ethics 19, 1087-1098, 2013 | 10 | 2013 |
| How to embed ethics into laboratory research P Buedo, I Odziemczyk, J Perek-Białas, M Waligora Accountability in Research, 2023 | 8 | 2023 |
| How informative were early SARS-CoV-2 treatment and prevention trials? A longitudinal cohort analysis of trials registered on ClinicalTrials.gov N Hutchinson, K Klas, BG Carlisle, J Kimmelman, W Marcin Plos One 17 (1), 2022 | 8 | 2022 |
| Clinical development success rates and social value of pediatric Phase 1 trials in oncology MT Wasylewski, K Strzebonska, M Koperny, M Polak, J Kimmelman, ... PLOS ONE, 2020 | 8 | 2020 |
| Participant protection in phase 1 pediatric cancer trials J Kimmelman, M Waligora, HF Lynch JAMA pediatrics 173 (1), 8-9, 2019 | 8 | 2019 |
| Child’s objection to non-beneficial research: capacity and distress based models M Waligora, J Różyńska, J Piasecki Medicine, Health Care and Philosophy 19, 65-70, 2016 | 8 | 2016 |
Jan PiaseckiJagiellonian University Medical CollegeVerified email at uj.edu.pl
